As of Sep 26
| -0.36 / -1.45%|
The 7 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 27.00, with a high estimate of 30.00 and a low estimate of 25.00. The median estimate represents a +10.57% increase from the last price of 24.42.
The current consensus among 9 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.